Cadrenal Therapeutics (CVKD) P/E (2023 - 2026)
Cadrenal Therapeutics (CVKD) P/E from Jan 20, 2023 to Jul 20, 2026. The TTM Cadrenal Therapeutics (CVKD) P/E is -0.38. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Cadrenal Therapeutics (CVKD)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.38 | -63.39% |
| 2025 | -1.05 | -41.28% |
| 2024 | -1.79 | +194.40% |
| 2023 | -0.61 | N/A |
Comparison Cadrenal Therapeutics (CVKD) P/E with competitors
Cadrenal Therapeutics (CVKD) P/E is -0.38.